Latest stories

  • in

    Etrasimod effective induction and maintenance therapy for moderate to severe active ulcerative colitis

    USA: A study published in The Lancet has concluded for patients which a history of moderate to severe active ulcerative colitis, Etrasimod is proven to be effective and well tolerated as an induction and maintenance therapy based on the study’s findings. They highlighted the therapeutic option further, saying, Etrasimod is a treatment capable of addressing […] More

  • in

    Timed births by scheduled induction or Cesarean delivery may significantly lower preeclampsia

    Timed births by scheduled induction or Cesarean delivery may significantly lower preeclampsia

    Researchers have found in a new research that More than half of all at-term preeclampsia cases that occur during weeks 37-42 of pregnancy  may be prevented with timed birth, such as a scheduled induction or Cesarean delivery. The new research has been published in Hypertension, a peer-reviewed journal of the American Heart Association. Preeclampsia is […] More